91202 ⎘
Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
Substituted (4-Hydroxyphenyl)Cycloalkane and (4-Hydroxyphenyl)Cycloalkene Compounds and Uses Thereof as Selective Agonists of the Estrogen Receptor Beta Isoform for Enhanced Memory Consolidation
#2NOVEL ROUTES OF CHEMICAL SYNTHESIS OF 20S(OH)D3, 20S,25(OH)2D3, 20S,23S(OH)2D3, AND 20S,23R(OH)2D3 AND THEIR MODIFICATION OF THE IMMUNE ACTIVITY OF PBMCS
#3HYDROGENATION CATALYST, PREPARATION METHOD FOR SAME, APPLICATIONS THEREOF, AND HYDROGENATION REACTION METHOD
#4TRANS-CYCLOOCTENES WITH HIGH REACTIVITY AND FAVORABLE PHYSIOCHEMICAL PROPERTIES
#5CATALYTIC CANNABINOID PROCESSES AND PRECURSORS
#6METHOD FOR PREPARING CANNABIDIOL COMPOUND
#7Substituted (4-Hydroxyphenyl)Cycloalkane and (4-Hydroxyphenyl)Cycloalkene Compounds and Uses Thereof as Selective Agonists of the Estrogen Receptor Beta Isoform for Enhanced Memory Consolidation
#8Biphenyl derivative compound and use thereof
#9Procedure for crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24-25-trihydroxy-19-nor-vitamin D
#10SHIP1 MODULATORS AND METHODS RELATED THERETO
#11Hydrogenation method for preparing hydrogenated bisphenol-A having a higher trans/trans isomer ratio
#12SHIP1 MODULATORS AND METHODS RELATED THERETO
#13SHIP1 modulators and methods related thereto
#14CYCLOPROPANE DERIVATIVES IN FLAVOR AND FRAGRANCE COMPOSITIONS
#15SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-METHYLENE ANALOGS OF CALCITRIOL AND RELATED COMPOUNDS
#16SHIP1 MODULATORS AND METHODS RELATED THERETO
#17Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds
#18Vitamin D analogues of pharmaceutical interest
#19Cyclopentanol compounds
#20Tobacco-derived components and materials
#21SHIP1 modulators and methods related thereto
#22Method for synthesising cyclohexenones and the use of same in the perfume industry
#23Cyclopentanol compounds
#24Cyclic compound containing functional group or containing no functional group, and method for producing same
#25Use of dicyclohexylmethanol derivatives having antimicrobial properties
#26Monomer for hardmask composition and hardmask composition including the monomer and method of forming patterns using the hardmask composition
#27CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS
#28Process for preparing xanthophyll crystal
#29Method for producing lutein from tobacco
#30Phenylcyclohexanol derivatives as wax modifiers and gelators
#31Oleoresins derived from a capsicum annuum exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
#32Cyclohexane compound and liquid crystal composition containing the same
#33CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS
#34Catalyst and process for hydrogenating aromatics
#35Catalyst, Method for Manufacturing the Same by Supercritical Fluid and Method for Hydrogenating an Aromatic Compound by Using the Same
#36Tobacco-derived components and materials
#37Indene derivatives as pharmaceutical agents
#38METHOD FOR PREPARING A TERPENYLCYCLOHEXANOL
#39NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS
#40INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#41Indene derivatives as pharmaceutical agents
#42RECYCLABLE METATHESIS CATALYSTS
#43Lutein extraction from ozone-treated plant sources
#44Vitamin Danalogues for the prevention and treatment of bone disorders
#45Indene derivatives as pharmaceutical agents
#46Paricalcitol purification
#47Solutions of anhydrous lanthanide salts and its preparation
#48Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
#49Optically enhanced chiral ionic liquids
#50Process for the manufacture of a composition containing at least one xanthophyll
#516-methyl-4-(2′,2′,3′-trimethyl-3′-cyclopenten-1′-yl)-2-cyclohexen-1-ol as sandal odoriferous substance
#52Process for production of cycloalkyl alkyl ethers
#53Iridium catalysts for catalytic hydrogenation
#54Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
#55Ligands for metals and improved metal-catalyzed processes based thereon
#56Vitamin Danalogues for the prevention and treatment of bone disorders
#57PROCESS FOR THE PRODUCTION OF 4,4-DIPHENYLCYCLOHEXANOL
#58Process for purification of free xanthophylls
#59Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates
#60Methods for the synthesis of astaxanthin
#61Method for the synthesis of astaxanthin
#62Methods for the synthesis of chiral dihydroxy intermediates useful for the chiral synthesis of carotenoids
#637-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes
#64Methods for the synthesis of unsaturated ketone intermediates useful for the synthesis of carotenoids
#65Methods for the synthesis of lutein
#66Vitamin D3 analog useful for the treatment of osteoporosis
#67Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids
#68Protected and unprotected triols for prostaglandin synthesis
#69Protected diols for prostaglandin synthesis
#70Methods for the synthesis of zeazanthin
#71Methods for the synthesis of astaxanthin
#72Ligands for metals and improved metal-catalyzed processes based thereon
#73Optically enhanced chiral ionic liquids
#74Recyclable metathesis catalysts
#75Prostaglandin synthesis
#76Solvents containing cycloakyl alkyl ethers and process for production of the ethers
#77Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants
#78Novel chiral auxiliary bearing resins
#79Cyclopentanone derivative
#80Indene derivatives as pharmaceutical agents